Barto v. Armstrong World Indus., Inc.

923 F. Supp. 1442, 44 Fed. R. Serv. 733, 1996 U.S. Dist. LEXIS 6370, 1996 WL 203292
CourtDistrict Court, D. New Mexico
DecidedApril 25, 1996
DocketCivil 89-932 BB
StatusPublished
Cited by3 cases

This text of 923 F. Supp. 1442 (Barto v. Armstrong World Indus., Inc.) is published on Counsel Stack Legal Research, covering District Court, D. New Mexico primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Barto v. Armstrong World Indus., Inc., 923 F. Supp. 1442, 44 Fed. R. Serv. 733, 1996 U.S. Dist. LEXIS 6370, 1996 WL 203292 (D.N.M. 1996).

Opinion

*1444 MEMORANDUM OPINION

BLACK, District Judge.

This Opinion addresses Defendant Owens-Coming Fiberglas’ (“OCF”) November 15, 1990 motion for summary judgment on product identification (Doc. 254). The Court has reviewed the submissions of the parties and the relevant law, and, for the reasons set forth below, finds that OCF’s motion is not well taken and should be DENIED.

I. Facts and Procedural History

Plaintiff Laura Barto (“Plaintiff’) and her decedent Floyd Barto (“Decedent”) filed this civil action in 1989 alleging that Decedent developed asbestos-related diseases as a result of his occupational exposure to asbestos products manufactured by OCF and others. OCF filed a motion for summary judgment on the issue of product identification on November 15, 1990. In July 1991, a Multi-District Litigation Panel transferred this action and several other asbestos-related cases to Judge Charles R. Weiner of the Eastern District of Pennsylvania. By Order of July 18,1994, Judge Weiner severed and retained the claims for punitive damages in this and other cases. Judge Weiner then remanded the remainder of the present matter to this Court for further proceedings. Thus, OCF’s November 15, 1990 motion for summary judgment is now before the Court.

II. Analysis

OCF asserts that it is entitled to summary judgment because Plaintiff has produced insufficient evidence that Decedent was exposed to any asbestos product manufactured by OCF. Summary judgment is appropriate only when there is no genuine issue of material fact and the movant is entitled to judgment as a matter of law. Quaker State Minit-Lube, Inc. v. Fireman’s Fund Ins. Co., 52 F.3d 1522, 1527 (10th Cir.1995). According to Federal Rule of Civil Procedure 56(c), the movant bears the burden of demonstrating the absence of a genuine issue of material fact. Celotex Corp. v. Catrett, 477 U.S. 317, 321-23, 106 S.Ct. 2548, 2552-58, 91 L.Ed.2d 265 (1986). On such a showing, “[a]n adverse party may not rest upon the mere allegations or denials of the adverse party’s pleading, but the adverse party’s response, by affidavits or as otherwise provided in this rule, must set forth specific facts showing that there is a genuine issue for trial.” Fed.R.Civ.P. 56(e). Viewing the evidence in the light most favorable to the non-movant, there is no issue for trial unless the Court finds sufficient evidence to support a verdict for the non-movant. Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 249, 106 S.Ct. 2505, 2511, 91 L.Ed.2d 202 (1986).

Plaintiffs action is one of strict products liability. In Brooks v. Beech Aircraft Corp., 120 N.M. 372, 902 P.2d 54 (1995), the New Mexico Supreme Court recently noted that strict products liability is especially appropriate to redress injuries caused by unreasonably dangerous products such as asbestos.

The burden of illness from dangerous products such as asbestos should be placed upon those who profit from its production and, more generally, upon society at large, which reaps the benefits of the various products our economy manufactures. That burden should not be imposed exclusively on the innocent victim.

Id. at 377, 902 P.2d at 59 (quoting Beshada v. Johns-Manville Prods. Corp., 90 N.J. 191, 447 A.2d 539, 549 (1982)). However, the Brooks court stressed that the burden sought to be eliminated by imposing strict liability is “the practical [one] of establishing the failure to exercise due care.” Id. The burden of proving that the defendant’s product caused the plaintiffs injury remains on the plaintiff even in a products liability action. See id. at 379, 902 P.2d at 61 (imposing “strict liability against manufacturers for injuries caused by defective product design”) (emphasis added). Thus, to prevail on her claims Plaintiff must produce evidence, viewed in the light most favorable to her position, sufficient to permit a reasonable juror to find in her favor on the issue of causation. Martin v. Unit Rig & Equip. Co., 715 F.2d 1434, 1439 (10th Cir.1983) (under New Mexico law proximate cause is essential element of claims in negligence and strict liability).

*1445 “[T]he general tort law definition of proximate cause is applicable in products liability eases,” except those premised on a failure to warn. N.M.U.J.I. 13-1424, Committee Comment. The New Mexico Uniform Jury Instructions state in pertinent part that

[t]he proximate cause of an injury is that which, in a natural and continuous sequence ... produces the injury and without which the injury would not have occurred. It need not be the only cause, nor the last nor nearest cause. It is sufficient if it occurs with some other cause, acting at the same time, which, in combination with it, causes the injury.

N.M.U.J.I. 13-1424. Proximate causation requires a plaintiff to demonstrate that the defendant’s act or product “actually aided in producing the injury.” Clay v. Ferrellgas, Inc., 114 N.M. 333, 337, 838 P.2d 487, 491 (Ct.App.1992), rev’d on other grounds, 118 N.M. 266, 881 P.2d 11 (1994).

OCF’s “product identification” argument is grounded on Plaintiffs asserted failure to show that OCF’s products actually caused Decedent’s illnesses. Thus, the narrow issue before the Court is whether Plaintiff has produced evidence that Decedent was sufficiently exposed to the asbestos products of OCF.

Plaintiff principally relies on Decedent’s own testimony to demonstrate that Decedent was sufficiently exposed to OCF’s asbestos products. Before the Court may consider the sufficiency of Decedent’s testimony, however, it must first address OCF’s argument that this evidence is inadmissible. Specifically, OCF argues that the Court should not consider Decedent’s deposition testimony regarding product identification because at the time he gave this testimony, Decedent was heavily medicated, the medication interfered with Decedent’s memory, and Decedent therefore lacked “capacity” to testify under Federal Rule of Evidence 602.

Federal Rule of Evidence

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Sinclair v. City of Grandview
973 F. Supp. 2d 1234 (E.D. Washington, 2013)
Hartford Fire Insurance v. Taylor
903 F. Supp. 2d 623 (N.D. Illinois, 2012)
United States v. Gould
563 F. Supp. 2d 1224 (D. New Mexico, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
923 F. Supp. 1442, 44 Fed. R. Serv. 733, 1996 U.S. Dist. LEXIS 6370, 1996 WL 203292, Counsel Stack Legal Research, https://law.counselstack.com/opinion/barto-v-armstrong-world-indus-inc-nmd-1996.